Top level regulators in Europe have rejected a recommendation that the European Medicines Agency create a dedicated sub-committee to deal with the current overload of applications for generic and biosimilar drugs that are awaiting review via its centralised procedure1-3...
Please login to read the full article.Welcome:
IBI01 - Circulation
scr
RAJ Pharma
EMA says no to sub-committee for handling generics overload
23 July 2010
Vibha Sharma
RELATED CONTENT
NEWS
RAJ Pharma News
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
RAJ Pharma Comment
Other Informa Comments
EVENTS
October 4th, 2010
London, UK
October 19th, 2010
Barcelona, Spain
October 20th, 2010
Barcelona, Spain